Finer MH - Search Results

1

A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.

Wang Q, Jia XC, Finer MH. Wang Q, et al. Among authors: finer mh. Gene Ther. 1995 Dec;2(10):775-83. Gene Ther. 1995. PMID: 8750018

2

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.

Wang Q, Greenburg G, Bunch D, Farson D, Finer MH. Wang Q, et al. Among authors: finer mh. Gene Ther. 1997 May;4(5):393-400. doi: 10.1038/sj.gt.3300404. Gene Ther. 1997. PMID: 9274715

3

Second-generation adenovirus vectors.

Wang Q, Finer MH. Wang Q, et al. Among authors: finer mh. Nat Med. 1996 Jun;2(6):714-6. doi: 10.1038/nm0696-714. Nat Med. 1996. PMID: 8640568 Review. No abstract available.

4

Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells.

Clark PR, Stopeck AT, Brailey JL, Wang Q, McArthur J, Finer MH, Hersh EM. Clark PR, et al. Among authors: finer mh. Cancer Gene Ther. 1999 Sep-Oct;6(5):437-46. doi: 10.1038/sj.cgt.7700074. Cancer Gene Ther. 1999. PMID: 10505854

5

Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.

Qian HS, Channon K, Neplioueva V, Wang Q, Finer M, Tsui L, George SE, McArthur J. Qian HS, et al. Circ Res. 2001 May 11;88(9):911-7. doi: 10.1161/hh0901.090926. Circ Res. 2001. PMID: 11349000

6

Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.

Hokanson CA, Dora E, Donahue BA, Rivkin M, Finer M, Mendez MJ. Hokanson CA, et al. Hum Gene Ther. 2003 Mar 1;14(4):329-39. doi: 10.1089/104303403321208934. Hum Gene Ther. 2003. PMID: 12659674

7

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.

Mendez MJ, Green LL, Corvalan JR, Jia XC, Maynard-Currie CE, Yang XD, Gallo ML, Louie DM, Lee DV, Erickson KL, Luna J, Roy CM, Abderrahim H, Kirschenbaum F, Noguchi M, Smith DH, Fukushima A, Hales JF, Klapholz S, Finer MH, Davis CG, Zsebo KM, Jakobovits A. Mendez MJ, et al. Among authors: finer mh. Nat Genet. 1997 Feb;15(2):146-56. doi: 10.1038/ng0297-146. Nat Genet. 1997. PMID: 9020839

8

Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.

Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568

9

Impact of chimeric immune receptor extracellular protein domains on T cell function.

Patel SD, Moskalenko M, Smith D, Maske B, Finer MH, McArthur JG. Patel SD, et al. Among authors: finer mh. Gene Ther. 1999 Mar;6(3):412-9. doi: 10.1038/sj.gt.3300831. Gene Ther. 1999. PMID: 10435091

10

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor.

McGuinness RP, Ge Y, Patel SD, Kashmiri SV, Lee HS, Hand PH, Schlom J, Finer MH, McArthur JG. McGuinness RP, et al. Among authors: finer mh. Hum Gene Ther. 1999 Jan 20;10(2):165-73. doi: 10.1089/10430349950018968. Hum Gene Ther. 1999. PMID: 10022542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters